Publications '99 - '02

13. David, J. P., Sabapathy, K., Hoffmann, O., Idarraga, M. H., & Wagner, E. F. (2002). JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. Journal of Cell Science, 115(Pt 22), 4317–4325. https://doi.org/10.1242/jcs.00082

12. Hochedlinger, K., Wagner, E. F., & Sabapathy, K. (2002). Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene, 21(15), 2441–2445. https://doi.org/10.1038/sj.onc.1205348

11. Behrens, A., Sabapathy, K., Graef, I., Cleary, M., Crabtree, G. R., & Wagner, E. F. (2001). Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proceedings of the National Academy of Sciences of the United States of America, 98(4), 1769–1774. https://doi.org/10.1073/pnas.98.4.1769

10. Sabapathy, K., Kallunki, T., David, J. P., Graef, I., Karin, M., & Wagner, E. F. (2001). c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. The Journal of Experimental Medicine, 193(3), 317–328.

https://doi.org/10.1084/jem.193.3.317

9. Sabapathy, K., Jochum, W., Hochedlinger, K., Chang, L., Karin, M., & Wagner, E. F. (1999). Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mechanisms of Development, 89(1-2), 115–124. https://doi.org/10.1016/s09254773(99)00213-0

8. De Graeve, F., Bahr, A., Sabapathy, K. T., Hauss, C., Wagner, E. F., Kedinger, C., & Chatton, B. (1999). Role of the ATFa/JNK2 complex in Jun activation. Oncogene, 18(23), 3491–3500. https://doi.org/10.1038/sj.onc.1202723

7. Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J. P., Jochum, W., Wagner, E. F., & Karin, M. (1999). JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Current Biology, 9(3), 116–125. https://doi.org/10.1016/s0960-9822(99)80065-7